The store will not work correctly when cookies are disabled.
US9162991, 15i
ID: ALA3979319
PubChem CID: 25023629
Max Phase: Preclinical
Molecular Formula: C16H13N3O
Molecular Weight: 263.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccccc1/C=C/C(=O)n1nnc2ccccc21
Standard InChI: InChI=1S/C16H13N3O/c1-12-6-2-3-7-13(12)10-11-16(20)19-15-9-5-4-8-14(15)17-18-19/h2-11H,1H3/b11-10+
Standard InChI Key: VKKNFGBVAOZQEJ-ZHACJKMWSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.9346 -8.9251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7600 -9.1707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2918 -10.5957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1764 -10.9028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1765 -9.7848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7083 -8.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7600 -8.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2256 -6.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2234 -5.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6890 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8631 -3.8341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 12 1 0
20 15 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.30 | Molecular Weight (Monoisotopic): 263.1059 | AlogP: 3.09 | #Rotatable Bonds: 2 |
Polar Surface Area: 47.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.49 | CX LogD: 3.49 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -1.36 |
References
1. (2015) Cinnamoyl inhibitors of transglutaminase, |